课题基金 / 基金详情

项目摘要

项目成果

BRUCE C. RICHARDSON的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):衰老T细胞亚群,其特征在于缺乏CD 28,在慢性炎症性疾病如类风湿性关节炎(RA)和急性冠状动脉综合征中随着衰老而发展。CD 4+亚群是促炎性和细胞毒性的,并且在死于心肌梗死的患者的发炎滑膜以及动脉粥样硬化斑块中发现,表明它们参与自身免疫性疾病过程。CD 4+亚群异常表达NK细胞免疫球蛋白样受体(KIR)基因和穿孔素(通常在NK细胞上发现),并过表达IFN-γ、LFA-1和CD 70。异常基因表达的原因尚不清楚。在初步研究中,我们发现正常T细胞具有KIR、穿孔素、IFN-γ、LFA-1和CD 70表达所必需的转录因子,但是这些基因的表达被关键调控元件的甲基化抑制,并且这些元件的去甲基化足以促进转录。此外,我们发现,总T细胞DMA去甲基化与年龄和RA,部分原因是DNA甲基转移酶(MTase)的减少,抑制T细胞ERK和JNK信号传导,以模拟减少的信号传导,发生与老化减少DNA MTase的表达和去甲基化DNA。最后,我们发现,CD 28提供共刺激信号增加DNA MTase表达。我们推测,DNA低甲基化,减少JNK和/或ERK信号,导致KIR,穿孔素,IFN-γ,LFA-1和CD 70的过度表达的CD 4+亚群在老化和RA,赋予促炎和细胞毒性功能。这将在3个具体目标中进行测试。我们将:1)比较CD 4+和CD 4+细胞中调控元件的甲基化状态和候选基因的表达。T细胞从RA患者和老年受试者,和CD 4?2)比较相同T细胞亚群中的DNA Mtase水平,然后选择性降低正常T细胞中的DNA Mtase水平并检查对候选基因甲基化和表达的影响,和3)比较相同T细胞亚群中的ERK和JNK途径信号传导,并检查降低的信号传导对DNA Mtase表达和候选基因甲基化、表达和功能的影响。这些研究将确定在这种病理亚群中改变基因表达的机制,并提出在这些细胞中恢复正常基因表达的方法。
英文摘要
DESCRIPTION (provided by applicant): A senescent T cell subset, characterized by the absence of CD28, develops with aging, in chronic inflammatory diseases like rheumatoid arthritis (RA), and in acute coronary syndromes. The CD4+ subset is proinflammatory and cytotoxic, and is found in inflamed synovium as well as atherosclerotic plaques of patients dying from myocardial infarction, suggesting they participate in autoimmune disease processes. The CD4+ subset aberrantly expresses killer-cell immunoglobulin-like receptor (KIR) genes and perforin, normally found on NK cells, and overexpresses IFN-y, LFA-1, and CD70. The reason for the aberrant gene expression is unknown. In preliminary studies we found that normal T cells have the transcription factors necessary for KIR, perforin, IFN-y, LFA-1 and CD70 expression, but expression of these genes is suppressed by methylation of crucial regulatory elements, and demethylation of these elements is sufficient to promote transcription. Further, we found that total T cell DMA demethylates with age and in RA, due in part to decreases in DNA methyltransferases (Mtase), and that inhibiting T cell ERK and JNK signaling to mimic the decreased signaling that occurs with aging decreases DNA Mtase expression and demethylates DNA. Finally, we found that CD28 provides costimulatory signals increasing DNA Mtase expression. We hypothesize that DNA hypomethylation, caused by decreased JNK and/or ERK signaling, results in the overexpression of KIR, perforin, IFN-y, LFA-1 and CD70 in the CD4+ subset in aging and RA, conferring pro-inflammatory and cytotoxic functions. This will be tested in 3 specific aims. We will: 1) Compare methylation status of regulatory elements and expression of the candidate genes in CD4+ and CD4? T cells from RA patients and elderly subjects, and to CD4? cells in controls, 2) Compare DNA Mtase levels in the same T cell subsets, then selectively decrease DNA Mtase levels in normal T cells and examine the effects on candidate gene methylation and expression, and 3) Compare ERK and JNK pathway signaling in the same T cell subsets, and examine the effects of decreased signaling on DNA Mtase expression and candidate gene methylation, expression and function. These studies will identify mechanisms modifying gene expression in this pathologic subset, and suggest ways to restore normal gene expression in these cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenomics of Systemic Autoimmunity
Does Demethylation of the Inactive X Contribute to Lupus in Women?
  • 批准号:
    8245569
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    BRUCE C. RICHARDSON
  • 依托单位:
Does Demethylation of the Inactive X Contribute to Lupus in Women?
  • 批准号:
    8398943
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    BRUCE C. RICHARDSON
  • 依托单位:
Does Demethylation of the Inactive X Contribute to Lupus in Women?
  • 批准号:
    8597403
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    BRUCE C. RICHARDSON
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: